Molecular Partners AG ADR (MOLN) — Cash Flow-to-Debt Ratio
Molecular Partners AG ADR (MOLN) has a Cash Flow-to-Debt Ratio of -0.63x as of June 2026, meaning its operating cash flow of $-10.81 Million could theoretically repay -1% of its total liabilities ($17.09 Million) in one year. See MOLN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Molecular Partners AG ADR Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Molecular Partners AG ADR across 13 annual periods. For the full cash flow conversion analysis, see MOLN cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Molecular Partners AG ADR (2013–2025)
Year-by-year debt coverage analysis for Molecular Partners AG ADR. Check MOLN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.35x | $-51.26 Million | $21.77 Million | ▲ +32.9% |
| 2024 | -3.51x | $-59.25 Million | $16.89 Million | ▼ -30.3% |
| 2023 | -2.69x | $-59.01 Million | $21.92 Million | ▼ -161.5% |
| 2022 | 4.38x | $118.57 Million | $27.09 Million | ▲ +414.6% |
| 2021 | -1.39x | $-90.95 Million | $65.38 Million | ▼ -285.6% |
| 2020 | -0.36x | $-28.98 Million | $80.33 Million | ▼ -1441.5% |
| 2019 | -0.02x | $-1.19 Million | $50.80 Million | ▲ +96.5% |
| 2018 | -0.67x | $-42.47 Million | $63.45 Million | ▲ +53.7% |
| 2017 | -1.45x | $-40.02 Million | $27.69 Million | ▼ -97.3% |
| 2016 | -0.73x | $-35.38 Million | $48.30 Million | ▼ -286.9% |
| 2015 | 0.39x | $26.50 Million | $67.60 Million | ▲ +257.5% |
| 2014 | -0.25x | $-11.33 Million | $45.54 Million | ▼ -13.0% |
| 2013 | -0.22x | $-13.61 Million | $61.80 Million | — |